KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Asset Writedowns and Impairment (2023 - 2025)

Biomarin Pharmaceutical's Asset Writedowns and Impairment history spans 6 years, with the latest figure at $122.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment rose 713.63% year-over-year to $122.0 million, compared with a TTM value of $125.0 million through Dec 2025, up 3733.01%, and an annual FY2025 reading of $125.0 million, changed N/A over the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $122.0 million at Biomarin Pharmaceutical, up from $3.0 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $122.0 million in Q4 2025, with the low at -$19.9 million in Q4 2024.
  • Average Asset Writedowns and Impairment over 3 years is $21.2 million, with a median of $9.7 million recorded in 2024.
  • Year-over-year, Asset Writedowns and Impairment crashed 242.06% in 2024 and then skyrocketed 713.63% in 2025.
  • Tracing BMRN's Asset Writedowns and Impairment over 3 years: stood at $14.0 million in 2023, then crashed by 242.06% to -$19.9 million in 2024, then skyrocketed by 713.63% to $122.0 million in 2025.
  • Per Business Quant, the three most recent readings for BMRN's Asset Writedowns and Impairment are $122.0 million (Q4 2025), $3.0 million (Q1 2025), and -$19.9 million (Q4 2024).